Last reviewed · How we verify

NCT05487222

Goal Directed and Liberal Fluid Therapy

Completed Last updated 4 August 2022
What this trial tests

trial testing ICON in Fluid Therapy in 100 participants. Completed in 20 September 2021.

Timeline
10 January 2020
Primary endpoint
15 June 2021
20 September 2021

Quick facts

Lead sponsorMansoura University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date10 January 2020
Primary completion15 June 2021
Estimated completion20 September 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Eligibility, any sex, with Fluid Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to compare intraoperative goal directed fluid therapy (GDFT) versus liberal fluid therapy in patients undergoing elective colorectal surgery by using noninvasive electrical cardiometry. This study hypothesized that GDFT is better than liberal fluid therapy to provide sufficient intra-vascular fluid volume for adequate perfusion without impairing glycolcalyx function with fluid overload

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fluid Therapy

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05487222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing